Vemurafenib-induced granuloma annulare

J Dtsch Dermatol Ges. 2016 Mar;14(3):305-8. doi: 10.1111/ddg.12777.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Diagnosis, Differential
  • Drug Eruptions / diagnosis*
  • Drug Eruptions / etiology
  • Drug Eruptions / pathology*
  • Female
  • Granuloma Annulare / chemically induced*
  • Granuloma Annulare / diagnosis
  • Granuloma Annulare / pathology
  • Humans
  • Indoles / adverse effects*
  • Indoles / therapeutic use
  • Melanoma / complications
  • Melanoma / drug therapy*
  • Melanoma / secondary*
  • Skin Neoplasms / complications
  • Skin Neoplasms / drug therapy*
  • Sulfonamides / adverse effects*
  • Sulfonamides / therapeutic use
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Vemurafenib